Cefa-iskia
Brand names,
Cefa-iskia
Analogs
Cefa-iskia
Brand Names Mixture
Cefa-iskia
Chemical_Formula
C16H17N3O4S
Cefa-iskia
RX_link
http://www.rxlist.com/cgi/generic/cephalex.htm
Cefa-iskia
fda sheet
Cefa-iskia
msds (material safety sheet)
Cefa-iskia
Synthesis Reference
R. B. Morin, B. G. Jackson, U.S. Pat. 3,275,626,861 (1966,1970)
Cefa-iskia
Molecular Weight
347.39 g/mol
Cefa-iskia
Melting Point
326.8oC
Cefa-iskia
H2O Solubility
1789 mg/L
Cefa-iskia
State
Solid
Cefa-iskia
LogP
0.019
Cefa-iskia
Dosage Forms
Capsules (containing cephalexin monohydrate equivalent to 250 mg or 500 mg cephalexin); Tablet (containing cephalexin monohydrate equivalent to 250 mg or 500 mg of cephalexin); Suspension
Cefa-iskia
Indication
For the treatment of respiratory tract infections caused by Streptococcus pneumoniae and Streptococcus pyogenes; otitis media due to Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Moraxella catarrhalis; skin and skin structure infections caused by Staphylococcus aureus and/or Streptococcus pyogenes; bone infections caused by Staphylococcus aureus and/or Proteus mirabilis; genitourinary tract infections, including acute prostatitis, caused by Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae.
Cefa-iskia
Pharmacology
Cephalexin (also called Cefalexin) is a first generation cephalosporin antibiotic. It is one of the most widely prescribed antibiotics, often used for the treatment of superficial infections that result as complications of minor wounds or lacerations. It is effective against most gram-positive bacteria.
Cefa-iskia
Absorption
Well absorbed from the gastrointestinal tract
Cefa-iskia
side effects and Toxicity
Symptoms of overdose include blood in the urine, diarrhea, nausea, upper abdominal pain, and vomiting. The oral median lethal dose of cephalexin in rats is >5000 mg/kg.
Cefa-iskia
Patient Information
Patients should be counseled that antibacterial drugs including Keflex should only be used to treat bacterial
infections. They do not treat viral infections (e.g., the common cold). When Keflex is prescribed to treat a
bacterial infection, patients should be told that although it is common to feel better early in the course of
therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of
therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria
will develop resistance and will not be treatable by Keflex or other antibacterial drugs in the future.
Cefa-iskia
Organisms Affected
Enteric bacteria and other eubacteria